Safety comparisons among monoamine oxidase inhibitors against Parkinson’s disease using FDA adverse event reporting system

Monoamine oxidase B (MAO-B) inhibitors are used to control Parkinson’s disease (PD). Selegiline, rasagiline, and safinamide are widely used as MAO-B inhibitors worldwide. Although these drugs inhibit MAO-B, there are pharmacological and chemical differences, such as the inhibitory activity, the non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Asano, Hiroto, Tian, Yu-Shi, Hatabu, Asuka, Takagi, Tatsuya, Ueda, Mikiko, Ikeda, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630381/
https://www.ncbi.nlm.nih.gov/pubmed/37935702
http://dx.doi.org/10.1038/s41598-023-44142-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630381/
https://www.ncbi.nlm.nih.gov/pubmed/37935702
http://dx.doi.org/10.1038/s41598-023-44142-2

Ejemplares similares